Key result
Serum 18-hydroxycorticosterone above 100 ng/dl identifies aldosterone-producing adenomas from adrenal hyperplasia with ~96% sensitivity.
Observational (n=53)
Answers are grounded in this paper and cite their sources.
Shows serum 18-hydroxycorticosterone distinguishes adenomas from hyperplasia in primary aldosteronism, suggesting its utility in identifying disease etiology.
Serum 18-hydroxycorticosterone, aldosterone, and potassium were measured under basal conditions in 34 patients with documented primary aldosteronism, 10 patients with essential hypertension, and 9 normal subjects. The results revealed that 22 of 23 patients with aldosterone-producing adenomas had 18-hydroxycorticosterone levels greater than 100 ng/dl, and all 9 patients with idiopathic adrenal hyperplasia had plasma levels less than 100 ng/dl. Two patients with unusual macromicronodular hyperplasia of the adrenal glands had levels greater than 100 ng/dl. We found a significant relationship between serum potassium and the ratio of 18-hydroxycorticosterone to aldosterone in patients with idiopathic adrenal hyperplasia, but not in those with an aldosterone-producing adenoma. We conclude that measurement of serum 18-hydroxycorticosterone is a useful predictor of the etiology of primary aldosteronism.
No takes yet. Share an insight, caveat, or question.
Kem et al. (1985) conducted an observational in Primary aldosteronism (n=53). Serum 18-hydroxycorticosterone measurement vs. Idiopathic adrenal hyperplasia vs aldosterone-producing adenoma was evaluated on Serum 18-hydroxycorticosterone levels >100 ng/dl to differentiate aldosterone-producing adenoma from idiopathic adrenal hyperplasia. Serum 18-hydroxycorticosterone >100 ng/dl distinguished aldosterone-producing adenomas from idiopathic adrenal hyperplasia.
Synapse has enriched 10 related papers. Consider them for comparative context: